• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cognex Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    5/1/25 4:24:08 PM ET
    $CGNX
    Industrial Machinery/Components
    Industrials
    Get the next $CGNX alert in real time by email
    cgnx-20250430
    0000851205FALSE00008512052025-04-302025-04-30

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________________
    FORM 8-K
    ___________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934

    April 30, 2025
    Date of Report (date of earliest event reported)
    ___________________________________
    Cognex Corporation
    (Exact name of registrant as specified in its charter)
    ___________________________________

    Massachusetts
    (State or other jurisdiction of
    incorporation or organization)
    001-34218
    (Commission File Number)
    04-2713778
    (I.R.S. Employer Identification Number)
    One Vision Drive
    Natick, Massachusetts 01760
    (Address of principal executive offices and zip code)
    (508) 650-3000
    (Registrant's telephone number, including area code)
    ___________________________________
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class
    Trading Symbol(s)
    Name of each exchange on which registered
    Common stock, par value $.002 per shareCGNXThe NASDAQ Stock Market LLC
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange
    Act. ☐




    Item 5.07     Submission of Matters to a Vote of Security Holders

    On April 30, 2025, Cognex Corporation (the “Company”) held its 2025 Annual Meeting of Shareholders (the “Meeting”). As of the record date for the Meeting, there were 169,370,136 shares of common stock of the Company outstanding and entitled to vote. The Company’s shareholders approved each of the proposals put to a vote as recommended by the Board of Directors. The proposals had been previously announced and described in the Company’s 2025 Proxy Statement filed with the Securities and Exchange Commission on March 14, 2025 (the “Proxy Statement”). The 156,432,936 shares represented at the Meeting were voted as follows:

    1.     The election of John T.C. Lee, Anthony Sun and Robert J. Willett as Directors to serve for a term ending in 2028. Each nominee for director was elected by a vote of the shareholders as follows:
    ForAgainstAbstainedBroker Non-Votes
    John T.C. Lee130,341,86711,474,0581,679,50512,937,506
    Anthony Sun113,577,68028,217,9651,699,78512,937,506
    Robert J. Willett140,553,2431,269,4631,672,72412,937,506

    2.    To ratify the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for fiscal year 2025. The proposal was approved by a vote of the shareholders as follows:

    For150,776,244
    Against3,960,028
    Abstained1,696,664
    Broker Non-Votes0

    3.    To approve, on an advisory basis, the compensation of the Company’s named executive officers as described in the Proxy Statement including the Compensation Discussion and Analysis, compensation tables and narrative discussion (“say-on-pay”). The proposal was approved by a vote of the shareholders as follows:

    For103,475,883
    Against37,074,762
    Abstained2,944,785
    Broker Non-Votes12,937,506

    No other matters were voted upon at the Meeting.



    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    COGNEX CORPORATION
    Dated: May 1, 2025
    By:
    /s/ Dennis Fehr
    Name:
    Dennis Fehr
    Title:
    Senior Vice President of Finance and Chief Financial Officer



    Get the next $CGNX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CGNX

    DatePrice TargetRatingAnalyst
    4/28/2025$35.00Hold → Buy
    TD Cowen
    2/21/2025$33.00Buy → Hold
    HSBC Securities
    12/20/2024$49.00Overweight
    Cantor Fitzgerald
    11/5/2024$46.00 → $43.00Buy → Hold
    Truist
    10/16/2024$45.00 → $55.00Equal-Weight → Overweight
    Stephens
    7/29/2024$48.00 → $57.00Buy
    Needham
    7/23/2024$58.00Buy
    Vertical Research
    5/7/2024Hold → Buy
    HSBC Securities
    More analyst ratings